Clinical and Neuroimaging Effects of Mindfulness-Based Cognitive Therapy for Symptomatic Obsessive-Compulsive Disorder Patients after First-Line Treatments: A Randomised Controlled Trial
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Introduction: Obsessive-compulsive disorder (OCD) is a chronic condition where many patients remain symptomatic despite first-line treatments such as cognitive behavioural therapy and selective serotonin reuptake inhibitors. This randomised controlled trial evaluated mindfulness-based cognitive therapy (MBCT) efficacy as an augmentation strategy and its impact on brain functional connectivity. METHODS: Sixty-eight participants with moderately symptomatic OCD were randomised into MBCT or treatment as usual (TAU). Clinical outcomes were evaluated using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Obsessive-Compulsive Inventory, alongside other relevant secondary outcomes. Data were analysed using repeated-measures ANOVA to assess time * group effects. Neuroimaging functional measures (resting-state network connectivity) were collected before and after the intervention and analysed using independent component analysis. RESULTS: Primary outcome: MBCT significantly reduced OCD symptoms compared to TAU (31.73% vs. 8.07% Y-BOCS reduction). SECONDARY OUTCOMES: the MBCT group also experienced reductions in depressive symptoms, rumination, perceived stress, and quality of life. No significant post-treatment changes were observed in resting-state connectivity. However, baseline connectivity demonstrated significant predictive value, with lower connectivity in preselected networks of interest, including the fronto-striatal, salience, and default mode networks, associated with greater reductions in Y-BOCS scores. CONCLUSION: MBCT is an effective strategy for individuals with moderately symptomatic OCD who continue to experience symptoms despite prior gold-standard treatments. While no post-treatment changes in brain functional connectivity were observed, baseline connectivity patterns predicted symptom reduction, suggesting a neural basis for MBCT response. .
Source: Psychotherapy and Psychosomatics
DOI: 10.1159/000548961
Authors: Maria Serra-Blasco, Neus Miquel-Giner, Muriel Vicent-Gil, Daniel Porta-Casteràs, Ignacio Martínez-Zalacaín, Marta Cano, Víctor De la Peña-Arteaga, Lorea Mar-Barrutia, Maria Alemany-Navarro, Carles Soriano-Mas, Marina López-Solà, Jessica R. Andrews-Hanna, Maria J. Portella, Joaquim Soler, Narcís Cardoner, Pino Alonso, Clara López-Solà
Institutions: Instituto de Salud Carlos III, Institut d'Investigació Biomédica de Bellvitge, Centro de Investigación Biomédica en Red de Salud Mental, Institut Català d'Oncologia, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Universitat Autònoma de Barcelona, Hospital de Sant Pau, Institut de Recerca Sant Pau, Bellvitge University Hospital, Hospital Universitario Araba, Osakidetza, Instituto de Biomedicina de Sevilla, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, University of Arizona, Hospital Clínic de Barcelona, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: hybrid
OpenAlex ID: W4415354176
